Helge Dorfmueller | Professor of Glycoengineering / Founder RHAPSEDA
University of Dundee

Helge Dorfmuller is a Principal Investigator at the University of Dundee, dedicated to advancing research and development in vaccines. With expertise in structural glycobiology and infectious diseases, he and his team explore the pathways responsible for generating bacterial surface carbohydrates. In recent years, Helge has been at the forefront of global vaccine innovation, focusing on engineering E. coli to produce dual-hit vaccine candidates that overcome the challenges of combining protein-based and carbohydrate-based components. His research tackles key obstacles in vaccine development, aiming to enhance production, efficacy, and accessibility. Through collaborations with leading global experts in vaccine development, including the International Vaccine Institute (IVI, Seoul, Korea) Helge strengthens global health initiatives by applying state-of-the-art vaccine technologies. He is founder of the Spin-off opportunity RHAPSEDA that implements the developed technology to target a variety of human and veterinary streptococcal pathogens.